9,10-Dihydro-2,5-dimethoxyphenanthrene-1,7-diol, from Eulophia ochreata, inhibits inflammatory signalling mediated by Toll-like receptorsRESEARCH PAPER

British Journal of Pharmacology

Volumn 160, Issue 5, 2010, Pages 1158-1170

  Datla, Praneel ^a   Kalluri, Mani Deepthi ^a   Basha, Khalander ^a   Bellary, Akshaya ^a   Kshirsagar, Rajendra ^a   Kanekar, Yogesh ^a   Upadhyay, Shakti ^a   Singh, Shiva ^a   Rajagopal, Vikram ^a  

^a RELIANCE LIFE SCIENCES PVT LTD   (India)

Author keywords

Eulophia ochreata; Inflammation; Lipopolysaccharide; Monocytes; TLR

Indexed keywords

9,10 DIHYDRO 2,5 DIMETHOXYPHENANTHRENE 1,7 DIOL; ANTIINFLAMMATORY AGENT; CARRAGEENAN; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; INTERLEUKIN 1BETA; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; PHENANTHRENE DERIVATIVE; RSCL 0520; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG; 9,10-DIHYDRO-2,5-DIMETHOXYPHENANTHRENE-1,7-DIOL; AUTACOID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG INHIBITION; DRUG ISOLATION; DRUG STRUCTURE; EULOPHIA OCHREATA; EXPERIMENTAL MODEL; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; IN VITRO STUDY; MALE; MEDICINAL PLANT; MOLECULAR MECHANICS; MONOCYTE; MOUSE; NONHUMAN; ORCHIDACEAE; PAW EDEMA; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; BLOOD; CELL LINE; CHEMICALLY INDUCED; DOSE RESPONSE; DRUG EFFECTS; EDEMA; HUMAN; INFLAMMATION; ISOLATION AND PURIFICATION; METABOLISM; SIGNAL TRANSDUCTION; WISTAR RAT;

ANIMALS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; EDEMA; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED BALB C; MONOCYTES; ORCHIDACEAE; PHENANTHRENES; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953206243     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.00780.x     Document Type: Article

References (47)

1. Aggarwal BB (2003). Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 3 : 745 756.
2. Alexander C, Rietschel ET (2001). Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res 7 : 167 202.
3. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA (2001). Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413 : 732 738.
4. Chen LF, Fischle W, Verdin E, Greene WC (2001). Duration of nuclear NF-κB action regulated by reversible acetylation. Science 293 : 1653 1657.
5. Darveau RP, Pham TT, Lemley K, Reife RA, Bainbridge BW, Coats SR et al. (2004). Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both Toll-like receptors 2 and 4. Infect Immun 72 : 5041 5051.
6. Dauphinee SM, Karsan A (2006). Lipopolysaccharide signaling in endothelial cells. Lab Invest 86 : 9 22.
7. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C (2004). Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303 : 1529 1531. (Pubitemid 38314425)
8. Dignam JD, Lebovitz RM, Roeder RG (1983). Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11 : 1475 1489.
9. Di Rosa M, Giroud JP, Willoughby DA (1971). Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine. J Pathol 104 : 15 29.
10. Egan LJ, Mays DC, Huntoon CJ, Bell MP, Pike MG, Sandborn WJ et al. (1999). Inhibition of interleukin-1-stimulated NF-κB RelA/p65 phosphorylation by mesalamine is accompanied by decreased transcriptional activity. J Biol Chem 274 : 26448 26453.
11. Estrada S, Toscano RA, Mata R (1999a). New phenanthrene derivatives from Maxillaria densa. J Nat Prod 62 : 1175 1178.
12. Estrada S, Rojas A, Mathison Y, Israel A, Mata R (1999b). Nitric oxide/cGMP mediates the spasmolytic action of 3,4′-dihydroxy-5,5′- dimethoxybibenzyl from Scaphyglottis livida. Planta Med 65 : 109 114.
13. Fargnoli J, Burkhardt AL, Laverty M, Kut SA, van Oers NS, Weiss A et al. (1995). Protein Syk mutation in Jurkat E6-derived clones results in lack of p72syk expression. J Biol Chem 270 : 26533 26537.
14. Fitzgerald KA, Palsson-McDermott EM, Bowie AG, Jefferies CA, Mansell AS, Brady G et al. (2001). Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413 : 78 83.
15. Fitzgerald KA, Rowe DC, Barnes BJ, Caffrey DR, Visintin A, Latz E et al. (2003). LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the Toll adapters TRAM and TRIF. J Exp Med 198 : 1043 1055.
16. Galanos C, Gumenscheimer M, Mühlradt P, Jirillo E, Freudenberg M (2000). MALP-2, a mycoplasma lipopeptide with classical endotoxic properties: end of an era of LPS monopoly? J Endotoxin Res 6 : 471 476.
17. Guha M, Mackman N (2001). LPS induction of gene expression in human monocytes. Cell Signal 13 : 85 94.
18. Hoebe K, Du X, Georgel P, Janssen E, Tabeta K, Kim SO et al. (2003). Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424 : 743 748.
19. Horng T, Barton GM, Medzhitov R (2001). TIRAP: an adapter molecule in the Toll signaling pathway. Nat Immunol 2 : 835 841.
20. Jiang Z, Ninomiya-Tsuji J, Qian Y, Matsumoto K, Li X (2002). Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1- induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol. Mol Cell Biol 22 : 7158 7167.
21. Kawai T, Akira S (2006). TLR signaling. Cell Death Differ 3 : 816 825.
22. Kawai T, Takeuchi O, Fujita T, Inoue J, Muhlradt PF, Sato S et al. (2001). Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol 167 : 5887 5894.
23. Laufer S (2003). Role of eicosanoids in structural degradation in osteoarthritis. Curr Opin Rheumatol 15 : 623 627.
24. Levy L (1969). Carrageenan-induced paw edema in the mouse. Life Sci 8 : 601 606.
25. Li S, Strelow A, Fontana EJ, Wesche H (2002). IRAK-4: a novel member of the RAK family with the properties of an IRAK-kinase. Proc Natl Acad Sci USA 99 : 5567 5572.
26. Majumder PL, Sen S, Majumder S (2001). Phenanthrene derivatives from the orchid Coelogyne cristata. Phytochemistry 58 : 581 586.
27. Meyer O (2003). Role of TNF-α and cytokines in the physiopathology of rheumatoid arthritis - therapeutic perspectives. Bull Acad Natl Med 187 : 935 954.
28. Nishimura M, Naito S (2005). Tissue-specific mRNA expression profiles of human Toll-like receptors and related genes. Biol Pharm Bull 28 : 886 892.
29. O'Neill LA, Dunne A, Edjeback M, Gray P, Jefferies C, Wietek C (2003). Mal and MyD88: adapter proteins involved in signal transduction by Toll-like receptors. J Endotoxin Res 9 : 55 59.
30. Oshiumi H, Matsumoto M, Funami K, Akazawa T, Seya T (2003). TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat Immunol 4 : 161 167.
31. Posadas I, Bucci M, Roviezzo F, Rossi A, Parente L, Sautebin L et al. (2004). Carrageenan-induced mouse paw oedema is biphasic, age-weight dependent and displays differential nitric oxide cyclooxygenase-2 expression. Br J Pharmacol 142 : 331 338.
32. Rocha AC, Fernandes ES, Quintão NL, Campos MM, Calixto JB (2006). Relevance of tumour necrosis factor-alpha for the inflammatory and nociceptive responses evoked by carrageenan in the mouse paw. Br J Pharmacol 148 : 688 695.
33. Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W (1999). IkB kinases phosphorylate NF-B p65 subunit on serine 536 in the transactivation domain. J Biol Chem 274 : 30353 30356.
34. Salvemini D, Wang ZQ, Wyatt PS, Bourdon DM, Marino MH, Manning PT et al. (1996). Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation. Br J Pharmacol 118 : 829 838.
35. Sandor F, Latz E, Re F, Mandell L, Repik G, Golenbock DT et al. (2003). Importance of extra- and intracellular domains of TLR1 and TLR2 in NFkappa B signaling. J Cell Biol 162 : 1099 1110.
36. Sierro F, Dubois B, Coste A, Kaiserlian D, Kraehenbuhl JP, Sirard JC (2001). Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration of dendritic cells. Proc Natl Acad Sci USA 98 : 13722 13727.
37. Sizemore N, Lerner N, Dombrowski N, Sakurai H, Stark GR (2002). Distinct roles of the IkB kinase alpha and beta subunits in liberating nuclear factor-κB (NF-κB) from IκB and in phosphorylating the p65 subunit of NF-κB. J Biol Chem 277 : 3863 3869.
38. Stokkers PC, Hommes DW (2004). New cytokine therapeutics for inflammatory bowel disease. Cytokine 28 : 167 173.
39. Takeda K, Akira S (2004). TLR signaling pathways. Semin Immunol 16 : 3 9.
40. Tuchinda P, Udchachon J, Khumtaveeporn K, Taylor WC, Engelhardt LM, White AH (1988). Phenanthrenes of Eulophia nuda. Phytochemistry 27 : 3267 3271.
41. Ulloa L, Tracey KJ (2005). The 'cytokine profile': a code for sepsis. Trends Mol Med 11 : 56 63.
42. Vollmer J, Weeratna R, Payette P, Jurk M, Schetter C, Laucht M et al. (2004). Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities. Eur J Immunol 34 : 251 262. (Pubitemid 38111541)
43. Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ (2001). TAK1 is an ubiquitin-dependent kinase of MKK and IKK. Nature 412 : 346 351.
44. Wesche H, Henzel WJ, Shillinglaw W, Li S, Cao Z (1997). MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7 : 837 847.
45. Winter CA, Risley EA, Nuss GW (1962). Carrageenan-induced oedema in hind paw of rat as assay for anti-inflammatory drugs. Proc Soc Exp Biol Med 111 : 544 547.
46. Yamamoto M, Sato S, Mori K, Hoshino K, Takeuchi O, Takeda K et al. (2002). Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J Immunol 169 : 6668 6672.
47. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H et al. (2003). Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 301 : 640 643. (Pubitemid 36927946)